Natural history of relapsed myeloma, refractory to immunomodulatory drugs and proteasome inhibitors: a multicenter IMWG studyShaji Kumar, B G M Durie, Meletios Α. Dimopoulos et al.|Leukemia|2017Cited by 356
The clinical relevance and management of monoclonal gammopathy of undetermined significance and related disorders: recommendations from the European Myeloma NetworkNiels W.C.J. van de Donk, Monika Engelhardt, Francesca Gay et al.|Haematologica|2014Cited by 175